Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Features of pharmacotherapy in the elderly patients. Introduction to the problem

https://doi.org/10.20996/1819-6446-2016-12-1-94-100

Full Text:

Abstract

Features of pharmacotherapy in the elderly patients are discussed. Data on the pharmacokinetics and pharmacodynamics, comorbidity, polypragmasy and treatment adherence among patients of this age group are presented.

About the Authors

E. A. Ushkalova
People's Friendship University of Russia. Miklukho-Maklaya ul. 6, Moscow, 117198 Russia
Russian Federation


O. N. Tkacheva
Russian Gerontological Research Clinical Center. Leonova Pervaya ul. 16, Moscow, 129226 Russia
Russian Federation


N. K. Runikhina
Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov. Oparina ul. 4, Moscow, 117997 Russia
Russian Federation


N. A. Chukhareva
Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov. Oparina ul. 4, Moscow, 117997 Russia
Russian Federation


A. Yu. Bevz
Russian Gerontological Research Clinical Center. Leonova Pervaya ul. 16, Moscow, 129226 Russia
Russian Federation


References

1. In Russia the share of the population older than working age exceeded 23% - the Ministry of Labour. Available at: http://www.finmarket.ru/news/3496901. Checked 01/20/2016. In Russian (В России доля населения страны старше трудоспособного возраста превысила 23% - Минтруда. Доступно на: http://www.finmarket.ru/news/3496901. Проверено 20.01.2016).

2. Pham CB, Dickman RL. Minimizing Adverse Drug Events in Older Patients. Am Fam Physician 2007;76(12):1837-44.

3. Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004;2(4):274-302.

4. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014;13(1):57-65.

5. Charlesworth CJ, Smit E, Lee DS, et al. Polypharmacy Among Adults Aged 65 Years and Older in the

6. United States: 1988-2010. J Gerontol A Biol Sci Med Sci 2015;70(8):989-95.

7. Belovol AN Kazakov II Clinical pharmacology in geriatrics. Medix Anti-aging 2012; 1 (25): 50-5. In Russian (Беловол А.Н., Князькова И.И. Клиническая фармакология в гериатрии. Medix Anti-aging 2012; 1(25): 50-5).

8. Wong DF, Pearlson GD, Tune LE, et al. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab 1997;17(3):331-42.

9. Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clin Ther 2014;36(11):1489-1511.e4.

10. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003;78: 1564-77.

11. Wooten JM., Pharmacotherapy Considerations in Elderly Adults. South Med J 2012;105(8):437-45.

12. Jansen PA, Brouwers JR Clinical pharmacology in old persons. Scientifica (Cairo) 012;2012:723678.

13. Mangoni AA, Jackson S D. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004;57(1):6-14.

14. TopinkováE, Baeyens JP, Michel JP, Lang PO. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012;29(6):477-94.

15. Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older subjects from ongoing clinical trials in heart failure. Arch Intern Med 2011; 171 (6): 550-6.

16. Olshansky SJ, Goldman DP, Zheng Y, Rowe JW. Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an aging society. The Milbank Quarterly 2009;87(4):842-62.

17. Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300(24):2867-78.

18. Held FP, Blyth F, Gnjidic D, et al. Association Rules Analysis of Comorbidity and Multimorbidity: The

19. Concord Health and Aging in Men Project. J Gerontol A Biol Sci Med Sci 2015 Oct 27. [Epub ahead of print].

20. Lazebnyk LB, Konev YV, Drozdov VN, Efremov LI. Polypharmacy: Geriatric aspect of the problem. Consilium-medicum 2007; 12: 29-34. In Russian (Лазебник Л.Б., Конев Ю.В., Дроздов В.Н., Ефремов Л.И. Полипрагмазия: гериатрический аспект проблемы. Consilium-medicum 2007; 12: 29-34).

21. Vetrano DL, Foebel AD, Marengoni A, et al. Chronic diseases and geriatric syndromes: The different weight of comorbidity. Eur J Intern Med 2016;27:62-7.

22. Franck L, Molyneux N, Parkinson L. Systematic review of interventions addressing social isolation and depression in aged care clients. Qual Life Res 2015 Dec 8. [Epub ahead of print]

23. Molinari E, Spatola C, Pietrabissa G, et al. The Role of Psychogeriatrics in Healthy Living and Active Ageing. Stud Health Technol Inform 2014;203:122-33.

24. Tjia J, Velten SJ, Parsons C, et al. Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging 2013;30:285-307.

25. Rossi MI, Young A, Maher R, et al. Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother 2007;5:317-23.

26. Hajjar E, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005;53:1518-23.

27. Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. Am Geriatr Soc 2006;54(10):1516-23.

28. Nobili A, Licata G, Salerno F, et al. Polypharmacy, length of hospital stay and inpatient mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 2011;67:507- 19.

29. Dwyer L, Han B, Woodwell D, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2009;8:63-72.

30. Bronskill S, Sudeep S, Gill MD, et al. Exploring variation in rates of polypharmacy across long term care homes. JAMDA 2012:309, e15-e21.

31. Beijer HJ, de Blaey CJ.Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2):46-54.

32. Lattanzio F, Landi F, Bustacchini S, et al. Geriatric conditions and the risk of adverse drug reactions in older adults: a review. Drug Saf 2012;35 Suppl 1:55-61.

33. Belousov YB, Gurevich KG Clinical pharmacokinetics. The practice of dispensing medication. Moscow: Litterra; 2005. In Russian (Белоусов Ю.Б., Гуревич К.Г. Клиническая фармакокинетика. Практика дозирования лекарств. Москва: Литтерра; 2005).

34. Kovalenko V., ed. Features of the application of drugs in elderly and senile age. Guidelines for cardiology. Kiev: Morion; 2008. In Russian (Коваленко В.Н., ред. Особенности применения лекарственных средств в пожилом и старческом возрасте. Руководство по кардиологии. Киев: Морион; 2008).

35. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002;(2):CD000011.

36. Bloom BS. Daily regimen and compliance with treatment. BMJ 2001;323(7314):647.

37. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288(4):455-61.

38. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984;6(5):592-9.

39. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23(8):1296-310.

40. Stegemann S, Ecker F, Maio M, et al. Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev 2010; 9: 384-98.


For citation:


Ushkalova E.A., Tkacheva O.N., Runikhina N.K., Chukhareva N.A., Bevz A.Y. Features of pharmacotherapy in the elderly patients. Introduction to the problem. Rational Pharmacotherapy in Cardiology. 2016;12(1):94-100. (In Russ.) https://doi.org/10.20996/1819-6446-2016-12-1-94-100

Views: 448


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)